Equity Research
Fundamental analysis, company comparisons, balance-sheet reviews, and equity valuation.
Backblaze Stock Analysis: Buy or Sell? Valuation, Margins & Leverage
Backblaze (BLZE) is rated Hold as revenue growth remains solid but margins are still negative and leverage is elevated. The stock looks reasonably valued on sales, yet operating profitability has not improved enough to support a more aggressive call.
CRISPR Therapeutics Stock Analysis: Buy or Sell? Valuation, Cash Burn & Growth Outlook
CRISPR Therapeutics AG (CRSP) is rated STRONG SELL as its valuation already prices in a much faster commercial ramp than current revenue and cash generation support. With heavy cash burn and negative operating cash flow, the stock leaves little margin for error despite a strong balance sheet.
Amgen Stock Analysis: Buy or Sell? Valuation, Cash Flow & Debt
Amgen (AMGN) is rated Hold because strong cash generation supports the business, but the valuation already reflects much of that quality. The key concern is elevated debt and policy-driven pricing pressure, which limit upside despite a 35.6% operating margin and solid free cash flow.
Intuitive Machines Stock Analysis: Buy or Sell? Cash Burn, Customer Risk & Valuation
Intuitive Machines (LUNR) is rated Strong Sell as revenue growth has not translated into durable profits or free cash flow. Rich valuation, persistent cash burn, and heavy customer concentration leave the stock vulnerable to execution misses.
Generac Holdings Stock Analysis: Buy or Sell? Valuation, Free Cash Flow & Leverage
Generac Holdings (GNRC) is rated Hold as valuation already discounts a recovery, while cash conversion remains modest. Strong free cash flow and manageable leverage support the case, but one-sided insider selling and a fair-to-slightly-rich multiple keep the stock in wait-and-see territory.
Copart Stock Analysis: Buy or Sell? Valuation, Cash Flow & Growth
Copart (CPRT) is rated Hold as strong cash generation and high margins are offset by slow 2.4% TTM growth and a valuation that is fair, not cheap. The key watchpoint is whether growth can re-accelerate enough to justify a rerating.
Target Stock Analysis: Valuation, Free Cash Flow, Margins & Risk
Target (TGT) is rated Hold as the stock already prices in a recovery that still has to prove itself in margins. The company remains profitable and cash generative, but valuation leaves limited room for disappointment if earnings momentum stalls.
Amkor Technology Stock Analysis: AMKR Free Cash Flow, Valuation & Customer Concentration
Amkor Technology (AMKR) is rated Sell as valuation remains rich while free cash flow is still negative. Customer concentration and heavy capex leave less room for execution mistakes, even with revenue growth and advanced-packaging strength.
Powell Industries Stock Analysis: Valuation, Backlog, Execution & Margins
Powell Industries (POWL) carries a HOLD rating as its backlog conversion and solid cash generation are offset by a premium valuation. With bookings down and the shares trading at elevated multiples, investors need clearer evidence of reaccelerating order flow.
Devon Energy Stock Analysis: Buy or Sell? Valuation, Cash Flow & Leverage
Devon Energy (DVN) is rated Hold as solid cash generation is offset by a valuation that already reflects much of the upside. Its cash flow is strong, but leverage and a soft current ratio limit the margin of safety.
Most Popular Research
Waitlist
Join the lf0 premium research waitlist.
More detailed equity research, scorecards, and performance analysis are coming. Add your email to be first in line.